Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PHEY | ISIN: SE0012308088 | Ticker-Symbol: M45
Frankfurt
22.01.25
08:02 Uhr
14,020 Euro
-0,280
-1,96 %
1-Jahres-Chart
TEQNION AB Chart 1 Jahr
5-Tage-Chart
TEQNION AB 5-Tage-Chart
RealtimeGeldBriefZeit
13,86014,54021:49
GlobeNewswire (Europe)
473 Leser
Artikel bewerten:
(2)

Teqnion AB: Teqnion acquires Nubis Solutions Limited

Finanznachrichten News

Teqnion AB has signed an agreement to acquire all outstanding shares in Nubis Solutions Limited.

Nubis Solutions, based in Cambridge, UK is a market leader in bespoke data centre and computer room containment designs and specialize in vendor neutral solutions to suit all applications and configurations. Richard and Leyton have since inception provided the world's leading data centric companies with the best solutions when it comes to safety and energy efficiency. The distinctively high level of quality and service have earned Nubis Solutions an almost impossible to replicate reputation as the go-to provider for the highest standard containment solutions in UK and Europe. The duo will continue to run the tight team of a dozen skilled coworkers just as if they still owned the company.

Nubis Solutions, just as most UK businesses has been deeply impacted by the Covid lockdowns, they still managed to deliver close to average £3 million in revenue with robust margins for the last 3 years.

"Nubis Solutions has grown steadily throughout its history. It continues to design and deliver cutting edge products to the data centre market helping improve the efficiency and safety of their data centres. With planned AI specific data centres designed for 80 MW consumption efficiency improvements have become mandatory.

However, after several fast-paced years of successful business growth it is time to move Nubis to its next owners to allow the company to continue on its journey. We will both continue to guide Nubis and to ensure it continues to flourish. Finding new owners with the same outlook has been difficult but with Teqnion we feel like we have found kindred spirits. We are inspired to work with Teqnion to take Nubis to the next level of excellence." Says Richard & Leyton, MD & sales director at Nubis Solutions.

"I'm very happy that we found the Nubis team since they are true Teqnion people. Very dedicated, driven and skilled, working closely with their customers in order to always deliver the best solution. It is a wonderful company, led by real gentlemen, acting in a time where we only expect data and processing capacity to increase, driving demand for Nubis systems. This will be fun!" says Johan Steene, CEO of Teqnion.

"It has been a very positive experience working with the Nubis and Teqnion teams and it is clear to me that the company will very much be in safe hands moving forward. I'm very happy to have been able to facilitate this transaction and to have successfully advised my clients in this key stage of their professional lives." says Fabio Rambelli at KBS corporate who represented the vendors in the transaction.

The acquisition is effective immediately and is not expected to have any significant effect on Teqnion's 2024 fiscal year financials.

The acquisition of Surge is Teqnion's fifth acquisition outside of Sweden and our fourth in the UK.

Read more https://nubissolutions.uk/ and at www.teqnion.se.

For more information, please contact:
Johan Steene, VD, phone: +46 73 333 57 33, E-mail: johan@teqnion.se
Daniel Zhang, CXO, phone: +46 721 555 695, E-mail: daniel@teqnion.se

Teqnion AB
Evenemangsgatan 31 A,
169 79 Solna
Phone: 08-655 12 00,
E-mail: info@teqnion.se

About Teqnion

Teqnion AB is an industrial group that acquires stable niche companies with good cash flows to develop and own with an eternal horizon. The subsidiaries are managed decentralized with support from the parent company. We operate in the majority of industries with leading products, which gives us good resistance to economic fluctuations as well as solid industrial know-how. For us, it is central to focus on profitability and long-term sustainable business relationships.

Teqnion's shares TEQ are traded on the Nasdaq First North Growth Market.

Redeye AB is Certified Adviser.

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.